4//SEC Filing
Hughes Eric A 4
Accession 0000950170-24-090329
CIK 0000818686other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 7:35 AM ET
Size
9.8 KB
Accession
0000950170-24-090329
Insider Transaction Report
Form 4
Hughes Eric A
See "Remarks"
Transactions
- Exercise/Conversion
Ordinary Shares
2024-08-01+52,742→ 69,597 total - Sale
Ordinary Shares
2024-08-01$17.25/sh−24,537$423,280→ 45,060 total - Exercise/Conversion
Restricted Share Units
2024-08-01−52,742→ 105,486 total→ Ordinary Shares (52,742 underlying)
Footnotes (6)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023.
- [F4]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.2502 to $17.2550, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F6]Restricted share units were granted on August 1, 2022, with 52,742 vested on each of August 1, 2023 and August 1, 2024, 52,742 vesting on August 1, 2025, and 52,744 vesting on August 1, 2026.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001938678
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 7:35 AM ET
- Size
- 9.8 KB